Literature DB >> 25627681

Roles of the NH2-terminal domains of cardiac ryanodine receptor in Ca2+ release activation and termination.

Yingjie Liu1, Bo Sun1, Zhichao Xiao1, Ruiwu Wang1, Wenting Guo1, Joe Z Zhang2, Tao Mi1, Yundi Wang1, Peter P Jones2, Filip Van Petegem3, S R Wayne Chen4.   

Abstract

The NH2-terminal region (residues 1-543) of the cardiac ryanodine receptor (RyR2) harbors a large number of mutations associated with cardiac arrhythmias and cardiomyopathies. Functional studies have revealed that the NH2-terminal region is involved in the activation and termination of Ca(2+) release. The three-dimensional structure of the NH2-terminal region has recently been solved. It is composed of three domains (A, B, and C). However, the roles of these individual domains in Ca(2+) release activation and termination are largely unknown. To understand the functional significance of each of these NH2-terminal domains, we systematically deleted these domains and assessed their impact on caffeine- or Ca(2+)-induced Ca(2+) release and store overload-induced Ca(2+) release (SOICR) in HEK293 cells. We found that all deletion mutants were capable of forming caffeine- and ryanodine-sensitive functional channels, indicating that the NH2-terminal region is not essential for channel gating. Ca(2+) release measurements revealed that deleting domain A markedly reduced the threshold for SOICR termination but had no effect on caffeine or Ca(2+) activation or the threshold for SOICR activation, whereas deleting domain B substantially enhanced caffeine and Ca(2+) activation and lowered the threshold for SOICR activation and termination. Conversely, deleting domain C suppressed caffeine activation, abolished Ca(2+) activation and SOICR, and diminished protein expression. These results suggest that domain A is involved in channel termination, domain B is involved in channel suppression, and domain C is critical for channel activation and expression. Our data shed new insights into the structure-function relationship of the NH2-terminal domains of RyR2 and the action of NH2-terminal disease mutations.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Calcium Imaging; Calcium Intracellular Release; Cardiac Muscle; Ryanodine Receptor; Sarcoplasmic Reticulum (SR)

Mesh:

Substances:

Year:  2015        PMID: 25627681      PMCID: PMC4367275          DOI: 10.1074/jbc.M114.618827

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Caffeine interaction with fluorescent calcium indicator dyes.

Authors:  M Muschol; B R Dasgupta; B M Salzberg
Journal:  Biophys J       Date:  1999-07       Impact factor: 4.033

2.  Ryanodine sensitizes the cardiac Ca(2+) release channel (ryanodine receptor isoform 2) to Ca(2+) activation and dissociates as the channel is closed by Ca(2+) depletion.

Authors:  G G Du; X Guo; V K Khanna; D H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Ryanodine sensitizes the Ca(2+) release channel (ryanodine receptor) to Ca(2+) activation.

Authors:  H Masumiya; P Li; L Zhang; S R Chen
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

4.  Molecular identification of the ryanodine receptor pore-forming segment.

Authors:  M Zhao; P Li; X Li; L Zhang; R J Winkfein; S R Chen
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

5.  Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor.

Authors:  Amy E Palmer; Can Jin; John C Reed; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-07       Impact factor: 11.205

Review 6.  Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies.

Authors:  Christopher H George; Hala Jundi; N Lowri Thomas; Debra L Fry; F Anthony Lai
Journal:  J Mol Cell Cardiol       Date:  2006-11-01       Impact factor: 5.000

7.  Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death.

Authors:  Dawei Jiang; Ruiwu Wang; Bailong Xiao; Huihui Kong; Donald J Hunt; Philip Choi; Lin Zhang; S R Wayne Chen
Journal:  Circ Res       Date:  2005-10-20       Impact factor: 17.367

8.  Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.

Authors:  Peter P Jones; Dawei Jiang; Jeff Bolstad; Donald J Hunt; Lin Zhang; Nicolas Demaurex; S R Wayne Chen
Journal:  Biochem J       Date:  2008-05-15       Impact factor: 3.857

9.  Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptor.

Authors:  Huihui Kong; Peter P Jones; Andrea Koop; Lin Zhang; Henry J Duff; S R Wayne Chen
Journal:  Biochem J       Date:  2008-09-15       Impact factor: 3.857

Review 10.  Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction.

Authors:  Donald M Bers
Journal:  Annu Rev Physiol       Date:  2013-11-13       Impact factor: 19.318

View more
  11 in total

Review 1.  Structure and Function of IP3 Receptors.

Authors:  David L Prole; Colin W Taylor
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-04-01       Impact factor: 10.005

2.  Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.

Authors:  Zhichao Xiao; Wenting Guo; Bo Sun; Donald J Hunt; Jinhong Wei; Yingjie Liu; Yundi Wang; Ruiwu Wang; Peter P Jones; Thomas G Back; S R Wayne Chen
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

3.  The Cytoplasmic Region of Inner Helix S6 Is an Important Determinant of Cardiac Ryanodine Receptor Channel Gating.

Authors:  Bo Sun; Wenting Guo; Xixi Tian; Jinjing Yao; Lin Zhang; Ruiwu Wang; S R Wayne Chen
Journal:  J Biol Chem       Date:  2016-10-27       Impact factor: 5.157

4.  The EF-hand Ca2+ Binding Domain Is Not Required for Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor.

Authors:  Wenting Guo; Bo Sun; Zhichao Xiao; Yingjie Liu; Yundi Wang; Lin Zhang; Ruiwu Wang; S R Wayne Chen
Journal:  J Biol Chem       Date:  2015-12-09       Impact factor: 5.157

5.  Novel RyR2 Mutation (G3118R) Is Associated With Autosomal Recessive Ventricular Fibrillation and Sudden Death: Clinical, Functional, and Computational Analysis.

Authors:  Ayelet Shauer; Oded Shor; Jinhong Wei; Yair Elitzur; Nataly Kucherenko; Ruiwu Wang; S R Wayne Chen; Yulia Einav; David Luria
Journal:  J Am Heart Assoc       Date:  2021-03-09       Impact factor: 5.501

Review 6.  The structural basis of ryanodine receptor ion channel function.

Authors:  Gerhard Meissner
Journal:  J Gen Physiol       Date:  2017-11-09       Impact factor: 4.086

7.  D,L-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca2+ release and decrease in Ca2+ efflux, elevating [Ca2+]i.

Authors:  JungKwon Lee; Jesusa L Rosales; Hee-Guk Byun; Ki-Young Lee
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

8.  The H29D Mutation Does Not Enhance Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor.

Authors:  Zhichao Xiao; Wenting Guo; Siobhan M Wong King Yuen; Ruiwu Wang; Lin Zhang; Filip Van Petegem; S R Wayne Chen
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

9.  R4496C RyR2 mutation impairs atrial and ventricular contractility.

Authors:  Cecilia Ferrantini; Raffaele Coppini; Beatrice Scellini; Claudia Ferrara; Josè Manuel Pioner; Luca Mazzoni; Silvia Priori; Elisabetta Cerbai; Chiara Tesi; Corrado Poggesi
Journal:  J Gen Physiol       Date:  2015-12-14       Impact factor: 4.086

10.  CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.

Authors:  Yingjie Liu; Jinhong Wei; Siobhan M Wong King Yuen; Bo Sun; Yijun Tang; Ruiwu Wang; Filip Van Petegem; S R Wayne Chen
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.